#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mitochondrial DNA depletion Blood iron increased Ureteric cancer Ataxia telangiectasia Acquired haemophilia Haemophagocytic lymphohistiocytosis Subdural haematoma Neuroendocrine cell hyperplasia of infancy Synovitis Frostbite Follicular lymphoma stage II Loeys-Dietz syndrome Soft tissue necrosis Bronchopulmonary aspergillosis Hypochromic anaemia More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Treatment Alexander disease – Treatment Pleomorphic leiomyosarcoma – Life with Disease Alport’s syndrome – Trials in Disease Brain stem glioma – Basic Information Gaucher’s disease type III – Basic Information Basal cell naevus syndrome – Diagnostics IgA nephropathy – Diagnostics Myelodysplastic syndrome – Treatment Hairy cell leukaemia recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Icosapent Ethyl Ribonucleic Acid K30 Etripamil Milrinone Afimetoran Besilate Dihydrate Dcc-3116 Nelarabine Minzasolmin Arbaclofen Namilumab 534 Florbetapir (18F) SAR445399 Fexofenadine Hydrochloride Urea LYSERGIDE Daptomycin Erythromycin Lactobionate Ivabradine Sucrose More therapies…

    Learn about Your Condition

    Diabetic nephropathy Kaposi's sarcoma Follicular lymphoma stage IV Pulmonary vascular disorder Pneumonia bacterial Neurotrophic keratopathy Seizure Chorea Hodgkin's disease recurrent Glaucoma Pancreatic carcinoma stage IV Polycystic ovarian syndrome Mucous membrane pemphigoid Essential hypertension Gender dysphoria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Specjalistyczny gabinet dermatologiczny Aplikacyjno-Badawczy…

Specjalistyczny gabinet dermatologiczny Aplikacyjno-Badawczy M. Brzewski, P. Brzewski S.C.

Ul. Zbożowa 2/25, Cracow, 30-002, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Bulgaria France Germany Greece +8

  • Study of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years

    Not recruiting

    3 1
    Czechia France Italy Poland Spain

  • Study of NT 201 compared to placebo in adults with moderate to severe platysma prominence

    Not recruiting

    3 1
    Investigated Diseases:
    • Muscle hypertrophy
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    France Germany Poland Spain

  • Study on the Effects of Ritlecitinib in Patients Aged 12 and Older with Alopecia Areata

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Alopecia areata
    Czechia Poland Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    • Ustekinumab
    Austria Belgium Denmark Germany Hungary Poland +2

  • Study on the Effectiveness and Safety of JNJ-95475939 and Dupilumab for Treating Moderate to Severe Atopic Dermatitis in Adults

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dupilumab
    Germany Poland Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Jnj-77242113
    • Ustekinumab
    Bulgaria Czechia Denmark Germany Hungary Poland +1

  • Study Comparing CT-P55 and Secukinumab for Moderate to Severe Plaque Psoriasis Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Secukinumab
    Poland

  • Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Pemphigoid
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Dupilumab
    France Germany Poland Spain

  • Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

    Not recruiting

    3 1
    Investigated Drugs:
    • Fezolinetant
    Czechia Denmark France Germany Hungary Italy +3
Previous Page
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!